TSEN54 and hepatocellular carcinoma: Deepening, we hired the UALCAN website and identified that not only can the differential expression of TSEN54 impinge on patient prognosis, but TSEN54 expression combined with clinicopathological features (e.g., grade and race) can also affect the survival of HCC patients (Figure 6F–6H).